How the Biosimilar Boom Boosts Drug Wholesalers’ Profits
Drug Channels
OCTOBER 18, 2022
The biosimilar boom for provider-administered drugs continues to accelerate. Net prices in therapeutic classes with biosimilar competition have declined by 60% or more over the past few years. Some major biological reference products have now lost a majority of their unit sales to their biosimilars. drug distribution.
Let's personalize your content